Horan Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
VF
JF
AIP
Horan Securities's LABU Position: Q1 2023 in Review
Horan Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 3 shares — an estimated $426 sold.
Horan Securities first reported a position in LABU in Q2 2022 and held it in 3 quarters. The position peaked at $426 in Q4 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.
- Horan Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
- Horan Securities sold 3 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $426.
- Horan Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 3 quarters.
- Horan Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $426 in Q4 2022.
- 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.
Based on Horan Securities's 13F filing for Q1 2023, filed 18 Apr 2023.